Table 1.

Starting and average bodyweight, organ weight at the end of the study and in vivo pQCT data of L4

Group	Non-Orx		Orx		Ostarine Therapy		Ostarine Proph.		Test. Therapy		Test. Proph.
	Mean	SD	Mean	SD	Mean	SD	Mean	SD	Mean	SD	Mean	SD
Starting body weight [g]#	717.5	70.5	713.3	75.3	687.9	81.7	715.8	71.2	680.2	74.3	703.4	82.3
Average body weight [g]§	730.2	29.6	669.5a	34.9	667.1a	33.5	683.7a	30.3	679.6a	25.3	663.7a	31.9
Prostate weight [g]#§	1.22	0.30	0.18a,d	0.07	0.39a	0.08	0.62a,b,e,f	0.13	0.19a	0.07	0.33a	0.13
Heart weight [g]	1.75	0.22	1.68	0.15	1.84	0.32	1.84	0.31	1.70	0.31	1.65	0.17
Liver weight [g]	23.1	3.9	19.7	2.4	20.5	1.9	20.7	5.2	20.1	0.5	20.8	2.9
Kidney weight [g]	4.0	0.6	3.5	0.5	3.9	0.6	4.2	0.5	3.3	0.2	3.5	0.6
Spleen weight [g]	1.40	0.23	1.46	0.15	1.35	0.28	1.55	0.27	1.33	0.14	1.58	0.44
Total BMD [mg/ccm] 12 weeks	535.0	46.53	476.2a	35.49	489.4	37.06	557.7b,c	50.23	493.3d	40.0	529.9b	49.54
Total BMD [mg/ccm] 18 weeks	475.3	32.38	430.2a	38.16	472.6	50.80	526.8a,b,c	46.11	465.5d	39.9	485.3b	23.91

^aDiffers from Non-Orx, ^bdiffers from Orx, ^cdiffers from Ostarine Therapy group, ^ddiffers from Ostarine Proph. group, ^ediffers from Test. Therapy group, ^fdiffers from Test. Proph. Group, (p > 0.05, Tukey-test)  

^#Published in [23]

^§Published in [22]